|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 17.20 USD | +2.69% |
|
+8.04% | -25.22% |
| 10-19 | Ultragenyx Pharmaceutical Enters Settlement With Navinta Over Dojolvi | MT |
| 10-14 | Ultragenyx Pharmaceutical to Sell Priority Review Voucher for $203 Million | DJ |
Stock exchange
Nasdaq
RARE 17.20 $
+2.69%
39.96M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| RARE | 17.20USD | +2.69% | 39.96M $ | ||
CBOE
| RARE | 17.22USD | +2.68% | 1.74M $ | |
|
Tradegate
| UP0 | 15.38EUR | +2.13% | 19.91K € | |
|
Berne S.E.
| UP0 | 10.76CHF | -16.55% | 1.61K CHF | |
|
Boerse Muenchen
| UP0 | 15.46EUR | +2.76% | 757.78 € | |
|
Mexican S.E.
| RARE * | 256.00MXN | +0.47% | 4.1K $ | |
|
Xetra
| UP0 | 15.43EUR | +2.70% | 61.72 € | |
|
Deutsche Boerse AG
| UP0 | 14.90EUR | +4.71% | 0 € | |
|
Börse Stuttgart
| UP0 | 15.26EUR | +2.01% | 0 € | |
| R2AR34 | 9.230BRL | +4.41% | 14.13K R$ |
Quotes 5-day view: Ultragenyx Pharmaceutical Inc.
Delayed Quote Nasdaq
| 2026-10-22 | 2026-10-23 | 2026-10-26 | 2026-10-27 | 2026-10-28 | |
|---|---|---|---|---|---|
| Last | US$15.95 | US$15.65 | US$16.08 | US$16.75 | US$17.22 |
| Volume | 2,374,276 | 1,789,661 | 3,023,155 | 4,944,537 | 2,310,725 |
| Change | +0.19% | -1.88% | +2.75% | +4.17% | +2.81% |
| Opening | US$15.78 | US$15.92 | US$15.75 | US$16.05 | US$16.73 |
| High | US$16.25 | US$15.94 | US$16.22 | US$16.96 | US$17.35 |
| Low | US$15.60 | US$15.49 | US$15.59 | US$15.88 | US$16.47 |
Performance
| 1 day | +2.69% | ||
| 1 week | +8.04% | ||
| Current month | +14.44% | ||
| 1 month | +19.36% | ||
| 3 months | -33.80% | ||
| 6 months | -29.88% | ||
| Current year | -25.22% | ||
| 1 year | -50.53% | ||
| 3 years | -47.58% | ||
| 5 years | -79.71% | ||
| 10 years | -72.53% |
Volumes
marketsDaily volume
2,323,533
Estimated daily volume
2,323,533
Avg. Volume 20 sessions
3,356,240
Daily volume ratio
0.69
Avg. Volume 20 sessions USD
57,727,328
Record volume 1
27,159,724
Record volume 2
21,699,768
Record volume 3
17,178,496
Capital turnover ratio
0.03
Float rotation
0.04
Basic data
Market Cap (USD)
1,646,338,622
Net sales (USD)
673,000,000
Number of employees
1,371
Sales / Employee (USD)
490,883
Free-Float
96.28%
Free-Float capitalization (USD)
1,594,688,289
Average Daily Capital Traded
3.51%
Indicators
Moving average 5 days
16.07
Moving average 20 days
15.22
Moving average 50 days
17.74
Moving average 100 days
22.8
Price spread / (MMA5)
-6.57%
Price spread / (MMA20)
-11.49%
Price spread / (MMA50)
+3.13%
Price spread / (MMA100)
+32.58%
STIM
RSI 9 days
59.42
RSI 14 days
51.33
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.69% | +8.04% | -50.53% | -47.58% | 1.65B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.41% | +1.22% | +31.52% | +64.01% | 402.92B | |
| Weighted average by Cap. | +0.26% | +0.71% | +44.46% | +88.96% |
Historical Quotes: Ultragenyx Pharmaceutical Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
364548c39570bfc290befa1475505ec.nh2GkSomcBnglBZd2lWV3zobQWcPQ-O0nwi6EZ_7Zso.70vO3B5SRjSS7G8biRn9lHtDFzA7D4_F63_SS86MDfnkfNPTbHQ9ftD3Rw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 17.20 | 226,783 | 1,670,043 |
| 15:59:58 | 17.22 | 100 | 1,443,260 |
| 15:59:57 | 17.21 | 100 | 1,443,160 |
| 15:59:57 | 17.21 | 100 | 1,443,060 |
| 15:59:57 | 17.21 | 100 | 1,442,960 |
| 15:59:57 | 17.21 | 200 | 1,442,860 |
| 15:59:57 | 17.21 | 100 | 1,442,660 |
| 15:59:57 | 17.21 | 146 | 1,442,560 |
| 15:59:57 | 17.21 | 150 | 1,442,414 |
| 15:59:56 | 17.21 | 200 | 1,442,264 |
Price Extremes
| 1 week | 15.49 |  | 17.35 |
| 1 month | 14.08 | | 17.35 |
| Current year | 12.73 | | 36.57 |
| 1 year | 12.73 | | 39.89 |
| 3 years | 12.73 | | 60.37 |
| 5 years | 12.73 | | 89.56 |
| 10 years | 12.73 | | 179.65 |
Monthly variations
Annual variations
| 2026 | -25.13% | ||
| 2025 | -45.33% | ||
| 2024 | -12.02% | ||
| 2023 | +3.22% | ||
| 2022 | -44.90% | ||
| 2021 | -39.25% | ||
| 2020 | +224.12% | ||
| 2019 | -1.77% | ||
| 2018 | -6.25% | ||
| 2017 | -34.03% | ||
| 2016 | -37.32% | ||
| 2015 | +155.65% | ||
| 2014 | +3.86% |
- Stock Market
- Stocks
- RARE Stock
- Quotes Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
